Abstract
References
- Winn W Jr, Allen S, Janda W, Koneman E, Procop G, Schreckenberger P, Woods G. Koneman’s color atlas and textbook of diagnostic microbiology, 6th edition. Lippincott Williams & Wilkins, Baltimore, MD. 2006.
- Coskun USS, Coskun G. Determination of the prevalence and antibiotic susceptibilities of extended spectrum beta-lactamase positive Escherichia coli strains ısolated from urine of outpatient patients of a state hospital. Kocatepe Tıp Derg. 2015;16:25-30.
- Mert D, Çeken S, Ertek M; İdrar yolu enfeksiyonlarında kültürden izole edilen bakteriler ve antibiyotik duyarlılıkları.Turk Hij. Den. Biyol Derg, 2020;77: 25-32.
- Forbes BA, Sahm DF, Weissfeld AS, Bailey WR. Bailey & Scott’s Diagnostic Microbiology. 12th Edition, Elsevier Mosby, St. Louis. 2007
- Atalay CR, Ertürk NK. Gebelikte üriner sistem enfeksiyonları; Turkiye Klinikleri J Urology-Special Topics 2018;11:92-5.
- Committee on Obstetric Practice. Committee Opinion No. 717: sulfonamides, nitrofurantoin, and risk of birth defects. Obstet Gynecol. 2017;130:e150-e152.
- Budak G, Budak S, Arı A, et all. Investigating the distribution of the bacteria that lead to urinary tract infections and antibiotic susceptibility of E. Coli. J Clin Anal Med. 2015;6:216-8.
- Johansen TE, Naber KG. Urinary Tract Infections. Antibiotics (Basel). 2014;3:375-7.
- Marcon J, Stief CG, Magistro G. [Urinary tract infections : What has been confirmed in therapy?] Der Internist. 2017 ;58:1242-9.
- Kahlmeter G, Poulsen HO. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited. Int J Antimicrob Agents. 2012;39:45-51.
- Zhanel GG, Karlowsky JA, Harding GK, et al. A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group. Antimicrob Agents Chemother. 2000;44:1089-92.
- Belete MA, Saravanan M. A systematic review on drug resistant urinary tract ınfection among pregnant women in developing countries in Africa and Asia; 2005-2016. Infect Drug Resist. 2020;13:1465-77.
- Forson AO, Tsidi WB, Nana-Adjei D, Quarchie MN, Obeng-Nkrumah N. Correction to: Escherichia coli bacteriuria in pregnant women in Ghana: antibiotic resistance patterns and virulence factors. BMC Res Notes. 2019;12:29.
- Dautt-Leyva JG, Canizalez-Román A, Acosta Alfaro LF, Gonzalez-Ibarra F, Murillo-Llanes J. Maternal and perinatal complications in pregnant women with urinary tract infection caused by Escherichia coli. J Obstet Gynaecol Res. 2018;44:1384-90.
- Shaeer KM, Zmarlicka MT, Chahine EB, Piccicacco N, Cho JC. Plazomicin: a next-generation aminoglycoside. Pharmacotherapy. 2019;39:77-93.
- Eljaaly K, Alharbi A, Alshehri S, Ortwine JK, Pogue JM. Plazomicin: a novel aminoglycoside for the treatment of resistant gram-negative bacterial ınfections. Drugs. 2019;79:243-69.
Retrospective analysis of urine culture results in our clinic: determination of pathogen types and antibiotic resistance in our region
Abstract
Aim: Untreated urinary tract infections and increasing resistance to antibiotics are important health problems in pregnant and non-pregnant women. The aim of this study is to determine "Escherichia coli" (E. coli) strains and other growing microorganisms isolated from urine samples sent from pregnant and non-pregnant patients in the Gynecology and Obstetrics outpatient clinic in Mardin State Hospital, and evaluate the antimicrobial susceptibility profile.
Materials and Methods: The results of reproduction in midstream urine samples obtained from pregnant and non-pregnant women who were sent to Mardin State Hospital Microbiology Laboratory with the suspicion of urinary system infection from the Gynecology and Obstetrics Outpatient Clinic between January 1, 2018 and June 17, 2020 were retrospectively evaluated.
Results: The mean age of pregnant patients was significantly lower than that of the non-pregnant group. While E. Coli and Klebsiella were prominent in the pregnant group, the incidence of E. Coli and Enterococcus sp. had increased in the non-pregnant group.
Conclusion: Urinary tract infection remains an important public health problem. To prevent the adverse obstetric consequences of urinary tract infection during pregnancy, it is important to investigate local susceptibility of microorganisms, especially common factors such as E. coli, at certain periods.
References
- Winn W Jr, Allen S, Janda W, Koneman E, Procop G, Schreckenberger P, Woods G. Koneman’s color atlas and textbook of diagnostic microbiology, 6th edition. Lippincott Williams & Wilkins, Baltimore, MD. 2006.
- Coskun USS, Coskun G. Determination of the prevalence and antibiotic susceptibilities of extended spectrum beta-lactamase positive Escherichia coli strains ısolated from urine of outpatient patients of a state hospital. Kocatepe Tıp Derg. 2015;16:25-30.
- Mert D, Çeken S, Ertek M; İdrar yolu enfeksiyonlarında kültürden izole edilen bakteriler ve antibiyotik duyarlılıkları.Turk Hij. Den. Biyol Derg, 2020;77: 25-32.
- Forbes BA, Sahm DF, Weissfeld AS, Bailey WR. Bailey & Scott’s Diagnostic Microbiology. 12th Edition, Elsevier Mosby, St. Louis. 2007
- Atalay CR, Ertürk NK. Gebelikte üriner sistem enfeksiyonları; Turkiye Klinikleri J Urology-Special Topics 2018;11:92-5.
- Committee on Obstetric Practice. Committee Opinion No. 717: sulfonamides, nitrofurantoin, and risk of birth defects. Obstet Gynecol. 2017;130:e150-e152.
- Budak G, Budak S, Arı A, et all. Investigating the distribution of the bacteria that lead to urinary tract infections and antibiotic susceptibility of E. Coli. J Clin Anal Med. 2015;6:216-8.
- Johansen TE, Naber KG. Urinary Tract Infections. Antibiotics (Basel). 2014;3:375-7.
- Marcon J, Stief CG, Magistro G. [Urinary tract infections : What has been confirmed in therapy?] Der Internist. 2017 ;58:1242-9.
- Kahlmeter G, Poulsen HO. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited. Int J Antimicrob Agents. 2012;39:45-51.
- Zhanel GG, Karlowsky JA, Harding GK, et al. A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group. Antimicrob Agents Chemother. 2000;44:1089-92.
- Belete MA, Saravanan M. A systematic review on drug resistant urinary tract ınfection among pregnant women in developing countries in Africa and Asia; 2005-2016. Infect Drug Resist. 2020;13:1465-77.
- Forson AO, Tsidi WB, Nana-Adjei D, Quarchie MN, Obeng-Nkrumah N. Correction to: Escherichia coli bacteriuria in pregnant women in Ghana: antibiotic resistance patterns and virulence factors. BMC Res Notes. 2019;12:29.
- Dautt-Leyva JG, Canizalez-Román A, Acosta Alfaro LF, Gonzalez-Ibarra F, Murillo-Llanes J. Maternal and perinatal complications in pregnant women with urinary tract infection caused by Escherichia coli. J Obstet Gynaecol Res. 2018;44:1384-90.
- Shaeer KM, Zmarlicka MT, Chahine EB, Piccicacco N, Cho JC. Plazomicin: a next-generation aminoglycoside. Pharmacotherapy. 2019;39:77-93.
- Eljaaly K, Alharbi A, Alshehri S, Ortwine JK, Pogue JM. Plazomicin: a novel aminoglycoside for the treatment of resistant gram-negative bacterial ınfections. Drugs. 2019;79:243-69.
Details
| Primary Language | English |
|---|---|
| Subjects | Health Care Administration |
| Journal Section | Original Article |
| Authors | |
| Publication Date | January 21, 2021 |
| Published in Issue | Year 2021 Volume: 4 Issue: 1 |
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].
The Directories (indexes) and Platforms we are included in are at the bottom of the page.
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show
The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.
|
|
|
| |
|
|
|
|
The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.
|
|
|
|
|
|
Our Journal using the DergiPark system indexed are;
Ulakbim TR Dizin, Index Copernicus, ICI World of Journals, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, OpenAIRE, MIAR, EuroPub, WorldCat (OCLC), DOAJ, Türkiye Citation Index, Türk Medline Index, InfoBase Index
Our Journal using the DergiPark system platforms are;
Journal articles are evaluated as "Double-Blind Peer Review".
Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user. https//dergipark.org.tr/tr/pub/jhsm/page/9535
Journal charge policy https://dergipark.org.tr/tr/pub/jhsm/page/10912
Editor List for 2022
Assoc. Prof. Alpaslan TANOĞLU (MD)
Prof. Aydın ÇİFCİ (MD)
Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)
Prof. Murat KEKİLLİ (MD)
Prof. Yavuz BEYAZIT (MD)
Prof. Ekrem ÜNAL (MD)
Prof. Ahmet EKEN (MD)
Assoc. Prof. Ercan YUVANÇ (MD)
Assoc. Prof. Bekir UÇAN (MD)
Assoc. Prof. Mehmet Sinan DAL (MD)
Our journal has been indexed in DOAJ as of May 18, 2020.
Our journal has been indexed in TR-Dizin as of March 12, 2021.
Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.